3 European Stocks Estimated To Be Up To 49.2% Below Intrinsic Value
The European market has recently faced challenges, with the STOXX Europe 600 Index ending the week down amidst global bond sell-offs and inflationary pressures. Despite these headwinds, opportunities may exist for investors to identify stocks trading below their intrinsic value, particularly in a climate where economic indicators like Germany's manufacturing resurgence and improved eurozone activity suggest underlying resilience. In such an environment, a good stock is often characterized by strong fundamentals that offer potential for growth when market sentiment stabilizes.
Top 10 Undervalued Stocks Based On Cash Flows In Europe
| Name | Current Price | Fair Value (Est) | Discount (Est) |
| Vitrolife (OM:VITR) | SEK91.30 | SEK181.26 | 49.6% |
| RaySearch Laboratories (OM:RAY B) | SEK181.20 | SEK356.80 | 49.2% |
| Nexstim (HLSE:NXTMH) | €9.16 | €18.17 | 49.6% |
| Mare Group (BIT:MARE) | €4.94 | €9.87 | 50% |
| Gabriel Holding (CPSE:GABR) | DKK264.00 | DKK523.26 | 49.5% |
| F-Secure Oyj (HLSE:FSECURE) | €2.01 | €3.96 | 49.2% |
| Execus (BIT:EXEC) | €1.02 | €2.01 | 49.1% |
| Dynavox Group (OM:DYVOX) | SEK74.90 | SEK148.92 | 49.7% |
| Dustin Group (OM:DUST) | SEK1.76 | SEK3.48 | 49.5% |
| BioMar Group (CPSE:BIOMAR) | DKK132.70 | DKK261.09 | 49.2% |
Let's uncover some gems from our specialized screener.
BioMar Group (CPSE:BIOMAR)
Overview: BioMar Group A/S, with a market cap of DKK13.30 billion, provides feeding solutions in the aquaculture industry in Denmark.
Operations: The company's revenue segments include DKK11.16 billion from Salmon, DKK2.46 billion from Shrimp, DKK161 million from Tech Solutions, and DKK3.04 billion from Selected Species.
Estimated Discount To Fair Value: 49.2%
BioMar Group is trading at DKK132.7, significantly below its estimated cash flow value of DKK261.09, indicating it may be undervalued based on cash flows. Despite high debt levels, BioMar's earnings are forecast to grow 12.9% annually, outpacing the Danish market's 7.1%. Recent earnings guidance was raised with expected revenue between DKK17-18 billion and EBIT between DKK1.2-1.3 billion for 2026, reflecting positive financial momentum post-IPO completion of DKK2.72 billion in May 2026.
- Our comprehensive growth report raises the possibility that BioMar Group is poised for substantial financial growth.
- Navigate through the intricacies of BioMar Group with our comprehensive financial health report here.
AB Volvo (OM:VOLV B)
Overview: AB Volvo (publ) is a global manufacturer and seller of trucks, buses, construction equipment, and marine and industrial engines across multiple continents with a market capitalization of approximately SEK705.43 billion.
Operations: The company's revenue segments are comprised of Industrial Operations - Trucks at SEK321.75 billion, Construction Equipment at SEK77.53 billion, Financial Services at SEK25.96 billion, Buses at SEK25.26 billion, and Volvo Penta at SEK20.83 billion.
Estimated Discount To Fair Value: 31%
AB Volvo is trading at SEK347, below its estimated cash flow value of SEK502.93, highlighting potential undervaluation. Despite debt not being well-covered by operating cash flow and a dividend yield of 3.75% not fully supported by free cash flows, the company shows robust growth prospects with earnings expected to grow 12.3% annually, surpassing the Swedish market's 7.3%. Recent Q2 results showed increased sales and net income compared to last year, reinforcing positive financial momentum.
- Our growth report here indicates AB Volvo may be poised for an improving outlook.
- Click here and access our complete balance sheet health report to understand the dynamics of AB Volvo.
Andritz (WBAG:ANDR)
Overview: Andritz AG provides industrial machinery, equipment, and services across various global markets with a market cap of €7.98 billion.
Operations: The company's revenue is derived from several segments, including Metals (€1.71 billion), Hydro Power (€1.83 billion), Pulp & Paper (€3.05 billion), and Environment & Energy (€1.49 billion).
Estimated Discount To Fair Value: 33.6%
Andritz AG is trading at €81.4, significantly below its estimated future cash flow value of €122.52, indicating potential undervaluation. The company's earnings are projected to grow 14.1% annually, outpacing the Austrian market's 9.7%. Recent Q2 results showed increased sales and net income year-over-year, supporting strong financial performance. Additionally, a strategic alliance with UPM aims to enhance tissue production innovation and efficiency, potentially bolstering future revenue streams amidst confirmed guidance for robust annual revenue growth.
- In light of our recent growth report, it seems possible that Andritz's financial performance will exceed current levels.
- Delve into the full analysis health report here for a deeper understanding of Andritz.
Taking Advantage
- Click this link to deep-dive into the 217 companies within our Undervalued European Stocks Based On Cash Flows screener.
- Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.
- Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.
Ready To Venture Into Other Investment Styles?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com